<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Healthcare Industry Today: Allergy Drugs News</title>
<link>http://health.einnews.com/news/allergy-drugs</link><description>Constantly updated news and information about healthcare industry.</description><item>
<title>New Findings Show Efficacy of Remicade Compared With Azathioprine in Treatment of Crohn&apos;s Disease According to First-of-its Kind Study</title>
<link>http://health.einnews.com/news.php?wid=191792101</link>
<pubDate>7 Oct 2008 01:55 GMT</pubDate>
<description>
...  not approved by the U.S. Food and Drug Administration (FDA) for the treatment of Crohn&apos;s  ...  monotherapy and combination therapy with the 2 drugs in patients with moderate to severe Crohn&apos;s  ...  disturbances or seizures while taking REMICADE.  Allergic reactions, some severe, have been reported during  ...
</description>
</item><item>
<title>Shire Announces Results from a Multidisciplinary Analysis of the Drug Release Profiles of LIALDA (mesalamine) and Asacol (mesalamine) for the Treatment of Ulcerative Colitis (UC) at the American College of Gastroenterology (ACG) M</title>
<link>http://health.einnews.com/news.php?wid=191792096</link>
<pubDate>7 Oct 2008 01:55 GMT</pubDate>
<description>
...  Results from a Multidisciplinary Analysis of the Drug Release Profiles of LIALDA (mesalamine) and Asacol  ...  LIALDA (mesalamine) and Asacol (mesalamine) for the Treatment of Ulcerative Colitis (UC) at the American  ...  treating patients with pyloric stenosis or those allergic to sulfasalazine. Mesalamine has been associated with  ...
</description>
</item><item>
<title>Celebrating Top Members-Project Vote-Getters: Spotlight on Eosinophilic Esophagitis</title>
<link>http://health.einnews.com/news.php?wid=191791340</link>
<pubDate>7 Oct 2008 01:53 GMT</pubDate>
<description>
...  throat and the stomach) caused by an allergic white blood cell, the eosinophil. Symptoms of  ...  of other diseases groups, such as food allergies, other eosinophil-associated diseases, and other immunologic-based diseases.  ...  of National Institute of Healths (NIH) Food Allergy Clinical Guideline Coordinating Committee. APFED is highly  ...
</description>
</item><item>
<title>Genes may explain racial disparities in asthma</title>
<link>http://health.einnews.com/news.php?wid=191764038</link>
<pubDate>6 Oct 2008 23:38 GMT</pubDate>
<description>
...  differences that lead to poor responses to drug therapy as the source of these racial  ...  by more than 400 specialists in and allergies at 283 study sites across the United  ...  the presence of other diseases and various allergy measures also did not explain the differences  ...
</description>
</item><item>
<title>3 Share Nobel For Work On AIDS, Cancer</title>
<link>http://health.einnews.com/news.php?wid=191758728</link>
<pubDate>6 Oct 2008 23:04 GMT</pubDate>
<description>
...  HIV are still alive thanks to new drug treatments. The announcement of the Nobel winners was  ...  and director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md., said  ...
</description>
</item><item>
<title>Greenway Medical Technologies&apos; Flagship EHR Solution, PrimeSuite, Complies with e-Prescribing Regulations Taking Effect</title>
<link>http://health.einnews.com/news.php?wid=191751468</link>
<pubDate>6 Oct 2008 22:28 GMT</pubDate>
<description>
...  demographics, dates of last visits and any drug allergies of which physicians and pharmacists must be  ...  pharmacy connectivity, health plan information, and patient medication history. More information about DrFirst can be  ...
</description>
</item><item>
<title>Greenway Medical Technologies&apos; Flagship EHR Solution, PrimeSuite, Complies with e-Prescribing Regula</title>
<link>http://health.einnews.com/news.php?wid=191751192</link>
<pubDate>6 Oct 2008 22:28 GMT</pubDate>
<description>
...  demographics, dates of last visits and any drug allergies of which physicians and pharmacists must be  ...  pharmacy connectivity, health plan information, and patient medication history. More information about DrFirst can be  ...
</description>
</item><item>
<title>Greenway Medical Technologies&apos; Flagship EHR Solution, PrimeSuite, Complies with e-Prescribing Regulations Taking Effect in January 2009</title>
<link>http://health.einnews.com/news.php?wid=191746726</link>
<pubDate>6 Oct 2008 22:08 GMT</pubDate>
<description>
...  demographics, dates of last visits and any drug allergies of which physicians and pharmacists must be  ...  pharmacy connectivity, health plan information, and patient medication history. More information about DrFirst can be  ...
</description>
</item><item>
<title>--&gt; Examine the Pfizer - Market Outlook for a Global Leader, 2008-2013</title>
<link>http://health.einnews.com/news.php?wid=191745842</link>
<pubDate>6 Oct 2008 22:04 GMT</pubDate>
<description>
...  Those challenges include Lipitor, the number-one selling drug in history and a product responsible for  ...  of Interest 2.4.1 Diseases 2.4.2 Neuroscience 2.4.3 Allergy &amp; Respiratory (A&amp;R) 2.4.4 Inflammation/Arthritis 2.4.5 Pain  ...  Forecast Period 4.6.1 Zyrtec Currently Leads the Allergic Rhinitis Market 4.7 Viagra Will Gradually Decline  ...
</description>
</item><item>
<title>Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Ov</title>
<link>http://health.einnews.com/news.php?wid=191742976</link>
<pubDate>6 Oct 2008 21:37 GMT</pubDate>
<description>
...  duration of 3 or more days requiring treatment with antibiotics and/or systemic (oral, intramuscular or  ...  Do not use SPIRIVA if you are allergic to atropine, ipratropium, tiotropium bromide, or lactose.  ...  ipratropium, tiotropium bromide, or lactose. A lactose allergy is not the same as lactose intolerance.  ...
</description>
</item><item>
<title>Examine the Pfizer - Market Outlook for a Global Leader, 2008-2013</title>
<link>http://health.einnews.com/news.php?wid=191742816</link>
<pubDate>6 Oct 2008 21:37 GMT</pubDate>
<description>
...  Those challenges include Lipitor, the number-one selling drug in history and a product responsible for  ...  of Interest 2.4.1 Diseases 2.4.2 Neuroscience 2.4.3 Allergy &amp; Respiratory (A&amp;R) 2.4.4 Inflammation/Arthritis 2.4.5 Pain  ...  Forecast Period 4.6.1 Zyrtec Currently Leads the Allergic Rhinitis Market 4.7 Viagra Will Gradually Decline  ...
</description>
</item><item>
<title>Shire announces results from an analysis of LIALDA and Asacol for the treatment of UC</title>
<link>http://health.einnews.com/news.php?wid=191738947</link>
<pubDate>6 Oct 2008 21:28 GMT</pubDate>
<description>
...  analysis of LIALDA and Asacol for the treatment of UC PHILADELPHIA October 6, 2008 Shire  ...  treating patients with pyloric stenosis or those allergic to sulfasalazine. Mesalamine has been associated with  ...  please visit LIALDA is part of a drug class called aminosalicylates, which contain 5-aminosalicyclic acid  ...
</description>
</item><item>
<title>New study finds summer is peak season for diagnosis of esophagus disorder</title>
<link>http://health.einnews.com/news.php?wid=191734247</link>
<pubDate>6 Oct 2008 21:10 GMT</pubDate>
<description>
...  that the diagnosis of EoE, previously termed &quot;allergic esophagitis,&quot; peaked during the summer months. The  ...  that, when released, are responsible for typical allergy type symptoms. In some people, allergies to either foods or environmental factors could  ...
</description>
</item><item>
<title>3 European scientists share Nobel medicine prize</title>
<link>http://health.einnews.com/news.php?wid=191733102</link>
<pubDate>6 Oct 2008 21:08 GMT</pubDate>
<description>
...  protecting against infection. The U.S. Food and Drug Administration approved the vaccine Gardasil in 2006  ...  the epidemic, and helped scientists develop anti-HIV drugs, the citation said. &quot;The combination of prevention  ...  Fauci, director of the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, agreed  ...
</description>
</item><item>
<title>Nobel Prize in medicine given for HIV, HPV discoveries</title>
<link>http://health.einnews.com/news.php?wid=191731305</link>
<pubDate>6 Oct 2008 20:58 GMT</pubDate>
<description>
...  supply screening and for the development of drugs to combat HIV in patients. In his  ...  this strain, the team cloned that and named it HPV-18. These discoveries by Harald zur  ...  and director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. The  ...
</description>
</item></channel>
</rss>
